Phase 2 Readout
Phase 2 Readout: bempikibart
- Company
- Q32 Bio Inc. (QTTB)
- Drug
- bempikibart
- Indication
- severe or very severe AA
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company